A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Prasugrel (Effient)

P2Y12 Platelet Inhibitor class · 6 generic manufacturers · 12 ANDAs filed at FDA.

First FDA approval2017-07-12
Generic availableYes · 6 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$38.7M in CY2024 Part D spend510K claims · 170K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.289/unit
15 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.300
Across all dosage forms in distribution.
Highest NADAC
$0.307
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Prasugrel used for?

Prasugrel is a P2Y12 Platelet Inhibitor medication tracked in Medicare Part D.

Is there a generic for Prasugrel?

Yes. 12 ANDAs filed at FDA, 6 generic manufacturers currently shipping.

How much does my plan pay for Prasugrel?

Across 329 Part D plans, Prasugrel averages $0.300/unit (NADAC). Lowest available: $0.289/unit. Highest in distribution: $0.307/unit.

Is Prasugrel on the FDA shortage list?

No. Prasugrel is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

P2Y12 Platelet Inhibitor4 alternatives in D1
01
Cangrelor
Brand: KENGREAL
Lowest NADAC
1Generic mfrs
CY24 Part D spend
Compare →
02
Clopidogrel
Brand: Plavix
$0.048Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Clopidogrel Bisulfate
Brand: CLOPIDOGREL
$0.048Lowest NADAC
15Generic mfrs
$243.7MCY24 Part D spend
Compare →
04
Ticagrelor
Brand: BRILINTA
$0.321Lowest NADAC
17Generic mfrs
$1.00BCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (15 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.